With the share price as a guide, I was anticipating some negative news about fee indexation in Australia or the reintroduction of a fee freeze in the US.
There also at least a portion of the share price decline attributable to the rise in interest rate expectations this year. US 10 year going ~3.8% to ~4.5% this year. Their business model is buying pathology businesses with debt.
Regardless, I did buy a few more today.
With the share price as a guide, I was anticipating some...
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.13 |
Change
-0.080(0.29%) |
Mkt cap ! $13.03B | |||
| Open | High | Low | Value | Volume |
| $27.18 | $27.59 | $27.01 | $20.38M | 749.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $27.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.15 | 2401 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| SHL (ASX) Chart |